Mesenchymal cells in the Lung: Evolving concepts and their role in fibrosis

G Ligresti, AA Raslan, J Hong, N Caporarello… - Gene, 2023 - Elsevier
Mesenchymal cells in the lung are crucial during development, but also contribute to the
pathogenesis of fibrotic disorders, including idiopathic pulmonary fibrosis (IPF), the most …

The role of MSC therapy in attenuating the damaging effects of the cytokine storm induced by COVID-19 on the heart and cardiovascular system

GM Ellison-Hughes, L Colley, KA O'Brien… - Frontiers in …, 2020 - frontiersin.org
The global pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
that causes coronavirus disease 2019 (COVID-19) has led to 47 m infected cases and 1. 2 m …

Proteomic biomarkers of progressive fibrosing interstitial lung disease: a multicentre cohort analysis

WS Bowman, CA Newton, AL Linderholm… - The Lancet …, 2022 - thelancet.com
Background Progressive fibrosing interstitial lung disease (ILD) is characterised by
parenchymal scar formation, leading to high morbidity and mortality. The ability to predict …

Autophagy, apoptosis, the unfolded protein response, and lung function in idiopathic pulmonary fibrosis

P Sharma, J Alizadeh, M Juarez, A Samali, AJ Halayko… - Cells, 2021 - mdpi.com
Autophagy, apoptosis, and the unfolded protein response (UPR) are fundamental biological
processes essential for manifold cellular functions in health and disease. Idiopathic …

[HTML][HTML] Transcriptional analysis of lung fibroblasts identifies PIM1 signaling as a driver of aging-associated persistent fibrosis

TX Pham, J Lee, J Guan, N Caporarello, JA Meridew… - JCI insight, 2022 - ncbi.nlm.nih.gov
Idiopathic pulmonary fibrosis (IPF) is an aging-associated disease characterized by
myofibroblast accumulation and progressive lung scarring. To identify transcriptional gene …

Inhibition of Aurora Kinase B attenuates fibroblast activation and pulmonary fibrosis

RK Kasam, S Ghandikota, D Soundararajan… - EMBO Molecular …, 2020 - embopress.org
Fibroblast activation including proliferation, survival, and ECM production is central to
initiation and maintenance of fibrotic lesions in idiopathic pulmonary fibrosis (IPF). However …

3D pulmonary fibrosis model for anti-fibrotic drug discovery by inkjet-bioprinting

D Kang, Y Lee, W Kim, HR Lee, S Jung - Biomedical Materials, 2022 - iopscience.iop.org
Pulmonary fibrosis (PF) is known as a chronic and irreversible disease characterized by
excessive extracellular matrix accumulation and lung architecture changes. Large efforts …

The role of DNA damage and repair in idiopathic pulmonary fibrosis

J Zhu, L Liu, X Ma, X Cao, Y Chen, X Qu, M Ji, H Liu… - Antioxidants, 2022 - mdpi.com
The mortality rate of idiopathic pulmonary fibrosis (IPF) increases yearly due to ineffective
treatment. Given that the lung is exposed to the external environment, it is likely that …

The role of immune cells in the pathogenesis of idiopathic pulmonary fibrosis

Y Xu, P Lan, T Wang - Medicina, 2023 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology with limited
treatment options. The role of the immune system in IPF has received increasing attention …

SEMA3B inhibits TGFβ-induced extracellular matrix protein production and its reduced levels are associated with a decline in lung function in IPF

DJK Yombo, S Ghandikota… - … of Physiology-Cell …, 2024 - journals.physiology.org
Idiopathic pulmonary fibrosis (IPF) is marked by the activation of fibroblasts, leading to
excessive production and deposition of extracellular matrix (ECM) within the lung …